MounjaroPalo Alto, CA

Mounjaro in Palo Alto, CA

In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Mounjaro® (Tirzepatide, Injectable pen) by Eli Lilly has been FDA-approved since 2022 for Type 2 diabetes. Weight Method offers a separate option for Palo Alto residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month — same pricing regardless of location.

FDA-approved Mounjaro prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Palo Alto is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Mounjaro in Palo Alto, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Mounjaro to patients in Palo Alto from $329/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Mounjaro® by Eli Lilly is the FDA-approved Injectable pen Tirzepatide product, taken Once weekly and approved in 2022 for Type 2 diabetes. Tirzepatide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Palo Alto residents: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month and includes the provider evaluation, the medication, ongoing care, and home delivery.

What treatment options are available locally?

Hispanic adults in Palo Alto face disproportionately high rates of obesity and type 2 diabetes — conditions that Tirzepatide therapy is studied for. Weight Method removes barriers that have historically limited access: our platform is fully bilingual, and our compounded Tirzepatide program (dispensed by a U.S.-licensed 503A pharmacy; compounded Tirzepatide is not FDA-approved) starts at $329/month with no insurance needed. Everything happens virtually from your Palo Alto home.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly. Weight Method prescribes compounded Tirzepatide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Tirzepatide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Tirzepatide is an appropriate option based on your medical history.

Weight Method's compounded Tirzepatide program starts at $329/month in Palo Alto. That price includes the medication, licensed provider consultations, and free home delivery. We don't bill insurance — there are no copays, no prior authorizations, and no surprise charges. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. Mounjaro® is a separate FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly; its retail price varies by pharmacy.

Weight Method is a telehealth program. You take an online health assessment, a licensed California provider reviews your history and meets with you virtually, and — if appropriate — they prescribe compounded Tirzepatide, which is dispensed by a U.S.-licensed 503A compounding pharmacy and shipped to your Palo Alto address. The $329/month price covers the medication, the virtual provider consultations, dosing management, and free delivery — there are no hidden fees. Compounded Tirzepatide is not FDA-approved.

Most patients complete their online assessment and virtual consultation within 24–48 hours. If your Weight Method provider determines that compounded Tirzepatide is appropriate for you, your prescription is typically shipped within 2–3 business days and arrives at your Palo Alto, CA address shortly after. The entire process from assessment to medication in hand usually takes less than a week. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

The most common side effects of Tirzepatide are gastrointestinal — mild nausea, decreased appetite, and occasional digestive discomfort. These typically occur during the first few weeks or after dose increases and diminish as your body adjusts. Your Weight Method provider follows a gradual dose-escalation protocol designed to reduce side effects and will monitor your progress throughout treatment. Discuss your full medical history with your provider before starting any GLP-1 therapy.

Start Your Treatment

Consult with a licensed provider in California and start Mounjaro from $329/month.

Get Started Now

Free consultation. No commitment.

Other Brands in Palo Alto

Nearby Cities

See More